Patrizia Cioli

Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans

P. Rossetti, F. Porcellati, P. Candeloro, 2008, Diabetes.

GREATER SUPPRESSION OF GLUCAGON, LIPOLYSIS AND KETOGENESIS WITH INSULIN GLARGINE U300 AS COMPARED TO GLARGINE U100 IN TYPE 1 DIABETES MELLITUS.

P. Lucidi, F. Porcellati, P. Candeloro, 2020, Diabetes technology & therapeutics.

Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans.

E. Ghigo, P. Lucidi, P. Rossetti, 2009, The Journal of clinical endocrinology and metabolism.

Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans

P. Lucidi, P. Rossetti, F. Porcellati, 2009, Diabetes.

Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People

K. Nair, P. Rossetti, F. Porcellati, 2008, Diabetes.

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes

P. Lucidi, P. Rossetti, F. Porcellati, 2012, Diabetes Care.

Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response study.

P. Lucidi, F. Porcellati, P. Candeloro, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

P. Lucidi, F. Porcellati, P. Candeloro, 2018, Diabetes Care.

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects

P. Lucidi, P. Rossetti, F. Porcellati, 2011, Diabetes Care.